Clinical Trials Sponsored by The National Retina Institute

Total 1895 results

The National Retina Institute
Genentech, Inc.

Completed

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Macular Degeneration

United States
Greater Houston Retina Research
The Methodist Hospital Research Institute

Completed

New Biopsy Technique for Uveal Melanoma

Uveal Melanoma

United States
Vital Art and Science Incorporated
National Eye Institute (NEI); University of Texas Southwestern Medical Center; Retina Foundation of the Southwest and other collaborators

Completed

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study (DRAMA)

Diabetic Retinopathy | Diabetic Macular Edema

United States
Regina Elena Cancer Institute
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

Completed

EXPERIMENTAL STUDY A.R.C.O. (CANCER CAREGIVER REMOTE ASSISTANCE)TELEHEALTH HOME MEDICATION VS/OUTPATIENT MEDICATION OF CENTRAL VENOUS CATHETER PICC (PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER) (ARCO)

Infections

Italy
ReThink Medical
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

A Study AnalyZing a NovEl Wearable SeNsor for Remote PatIent Health Monitoring (ZENITH)

Heart Failure | Chronic Kidney Diseases

United States
National Cancer Institute, Naples
Baxter Healthcare Corporation; Fondazione IRCCS Istituto Nazionale dei Tumori... and other collaborators

Active, not recruiting

A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures (Hemopatch)

Thoracic Surgery Lung | Post-operative Thoracic Air Leak

Italy
The Alfred
National Trauma Research Institute

Completed

Rest Easy: Is Bed Rest Really Necessary After Surgical Repair of an Ankle Fracture?

Ankle Injuries | Fracture

Australia
Retain Health, Inc
National Institute on Aging (NIA); University of Cincinnati

Active, not recruiting

The Retain Your Brain Health Study (RetainYourBrain.Com)

Dementia | Alzheimer Disease | Healthy Participants | Brain Health

United States
The Cleveland Clinic
National Eye Institute (NEI)

Recruiting

DISCOVER Study: Microscope-integrated Intraoperative OCT Study (DISCOVER)

Retinal Diseases | Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular Hole

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer

Prostate Cancer

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Terminated

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Cancer

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Kidney Cancer

United States
The Miriam Hospital
National Cancer Institute (NCI)

Completed

Consistency in Individual Differences in Energy Intake Following Acute Exercise

Obesity | Sedentary

United States
The Cleveland Clinic

Unknown

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
The Vaccine Company

Unknown

Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States
The Cleveland Clinic

Completed

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
National Cancer Institute (NCI)
The Cleveland Clinic

Completed

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma

Kidney Cancer | Melanoma (Skin)

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)
The Cleveland Clinic
National Cancer Institute (NCI)

Terminated

Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease

Actinic Keratosis | Organ or Tissue Transplant; Complications

United States
National Jewish Health
The Scripps Research Institute

Suspended

Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD) (AERD)

Nasal Polyps | Aspirin Exacerbated Respiratory Disease | Aspirin-Sensitive Asthma

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Brain Tumor | Central Nervous System Tumors

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma

Multiple Myeloma | Anemia | Plasma Cell Neoplasm

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Psychosocial Effects of Cancer and Its Treatment

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Terminated

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Precancerous/Nonmalignant Condition | Secondary Myelofibrosis | Multiple Myeloma and Malignant Plasma Cell Neoplasms

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Terminated

Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer

Non-melanomatous Skin Cancer
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma (IFNa)

Melanoma | Sarcoma | Lymphoma | Kidney Cancer | Breast Cancer | Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific

United States
The Miriam Hospital
National Cancer Institute (NCI)

Completed

Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?

Lung Cancer | Heart Disease | COPD

United States
The Cleveland Clinic

Unknown

Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor

Metastatic Cancer

United States
The Vaccine Company

Unknown

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

Leukemia

United States
The Cleveland Clinic

Unknown

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Drug/Agent Toxicity by Tissue/Organ

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Unknown

Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy

Breast Cancer

United States
The Cleveland Clinic

Completed

Rituximab in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Lymphoma

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Leukemia
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

United States
The Cleveland Clinic
National Eye Institute (NEI)

Completed

PIONEER: Intraoperative and Perioperative OCT Study (PIONEER)

Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular Hole

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
The Cleveland Clinic

Completed

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
The Cleveland Clinic

Withdrawn

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell Neoplasm

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
Children's National Research Institute
AppleTree Institute; The Maddux School

Enrolling by invitation

Development and Pilot Testing of a Novel Preschool Executive Function Curriculum

Executive Dysfunction

United States
Karolinska Institutet
The National Gambling Helpline Sweden

Not yet recruiting

Internet Based Self-help for Problem Gambling Concerned Significant Others

Problem Gambling
The Alfred
National Institutes of Health (NIH)

Completed

Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History

HIV Infections | Hepatitis B

Australia
Lawson Health Research Institute
Canadian National Institute for the Blind

Completed

Canadian Eye Injury Registry (CEIR)

Eye Injuries

Canada
The Scripps Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults (SCCAN)

Cannabis Dependence | Cannabis Withdrawal

United States
The Scripps Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Gabapentin Treatment of Cannabis Dependence

Cannabis Dependence | Cognitive Deficits | Cannabis Withdrawal

United States

Clinical Trials Sponsored by The National Retina Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations